Carbylan's osteoarthritis drug meets one of two main goals

(Reuters) - Carbylan Therapeutics Inc said its experimental drug to treat pain associated with osteoarthritis of the knee met one of its main goal in a late-stage trial.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro